Life Healthcare has tested the overbought line. There is now a high volume rejection and the downtrend can be expected to continue. This is confirmed by negative divergence in the volume RSI and a downward trending relative strength to the Top40.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.